KCNJ10 and epilepsy: In a more recent study, co-injection of the kcnj10a morpholino with mRNA from patients with KCNJ10 mutations related to autism spectrum disorder and epilepsy did not rescue the phenotype, while normal human KCNJ10 mRNA did.